Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2018 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Net interest income -- -- -- --
Total op income 43.20 (23) (79) (95)
Op profit (pre-provision) (0.90) (16) 307 (102)
Net profit 45,879 (45) 296 (102)
Advances (15) (13) (0.10) 0.11
Borrowings -- (100) 100 --
Total assets (24) (0.10) (0.10) --
Profitability Ratios (%)        
NIM -- -- -- --
Non-int inc/Total inc 100 100 100 100
Return on Avg Equity (28) (0.10) (0.10) --
Return on Avg Assets (28) (0.10) (0.10) --
Per share ratios ()        
EPS -- -- -- --
Adj.BVPS -- -- -- --
DPS -- -- -- --
Other key ratios (%)        
Loans/Borrowings 32,333 -- 65,550 131,200
Cost/Income 104 82.90 126 158
CAR -- -- -- --
Tier-I capital -- -- -- --
Gross NPLs/Loans -- -- -- --
Prov/Avg loans -- -- -- --
Net NPLs/Net loans -- -- -- --
Tax rate -- 0.44 (0.10) (0.10)
Dividend yield -- -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Interest income -- -- -- --
Interest expense -- -- -- --
Net interest income -- -- -- --
Non-interest income 0.09 0.06 0.08 0.39
Total op income 0.09 0.06 0.08 0.39
Total op expenses (0.60) (0.60) (0.70) (0.50)
Op profit (pre-prov) (0.50) (0.50) (0.60) (0.10)
Provisions -- -- -- --
Exceptionals (158) -- -- --
Profit before tax (158) (0.50) (0.60) (0.10)
Taxes (0.20) 0.15 -- --
Net profit (158) (0.30) (0.60) (0.20)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2019 Mar-2018 Mar-2017 Mar-2016
Equity Capital 10.50 10.50 10.50 10.50
Reserves 89 483 636 636
Net worth 99.50 493 646 647
Long-term borrowings -- -- -- --
Other Long-term liabilities -- -- -- --
Long term provisions -- -- 0.02 0.01
Total Non-current liabilities -- -- 0.02 0.01
Short Term Borrowings -- -- -- --
Trade payables 0.03 0.02 0.07 0.10
Other current liabilities 0.05 0.06 -- 0.04
Short term provisions -- 0.02 -- --
Total Current liabilities 0.08 0.10 0.07 0.14
Total Equities and Liabilities 99.60 493 646 647
Fixed Assets -- -- -- --
Non-current investments 96.30 471 620 616
Deferred tax assets (Net) 3.32 3.31 0.16 --
Long-term loans and advances -- -- 3.32 3.32
Other non-current assets -- -- -- --
Total Non-current assets 99.60 474 623 619
Current investments -- -- 3.92 4.48
Trade receivables -- -- -- --
Cash and cash equivalents -- 0.04 0.05 0.06
Short-term loans and advances -- 19.40 19.40 22.90
Other current assets -- -- -- --
Total Current assets -- 19.40 23.40 27.40
Total Assets 99.60 493 646 647
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2020 Dec-2019 Sep-2019 Jun-2019
Gross Sales -- -- -- --
Excise Duty -- -- -- --
Net Sales -- -- -- --
Other Operating Income -- -- -- --
Other Income 0.02 -- -- --
Total Income 0.02 -- -- --
Total Expenditure ** 75.60 -- 0.58 0.88
PBIDT (76) 0.04 (0.60) (0.90)
Interest -- -- -- --
PBDT (76) 0.04 (0.60) (0.90)
Depreciation -- -- -- --
Tax -- -- -- --
Fringe Benefit Tax -- -- -- --
Deferred Tax -- -- -- --
Reported Profit After Tax (76) 0.04 (0.60) (0.90)
Extra-ordinary Items -- -- -- --
Adjusted Profit After Extra-ordinary item (76) 0.04 (0.60) (0.90)
EPS (Unit Curr.) (72) 0.04 (0.60) (0.80)
EPS (Adj) (Unit Curr.) (72) 0.04 (0.60) (0.80)
Calculated EPS (Unit Curr.) (72) 0.04 (0.60) (0.80)
Calculated EPS (Adj) (Unit Curr.)  (72) 0.04 (0.60) (0.80)
Calculated EPS (Ann.) (Unit Curr.) (288) 0.15 (2.20) (3.40)
Calculated EPS (Adj) (Ann.) (Unit Curr.)  (288) 0.15 (2.20) (3.40)
Book Value (Unit Curr.) -- -- -- --
Dividend (%) -- -- -- --
Equity 10.50 10.50 10.50 10.50
Reserve & Surplus -- -- -- --
Face Value 10 10 10 10
Public Shareholding (No Of.Shares)  -- -- -- --
Public Shareholding (% in Equity)  -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- --
Non Encumbered - No. of Shares -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- --
Non Encumbered - % in Total Equity -- -- -- --
PBIDTM(%) -- -- -- --
PBDTM(%) -- -- -- --
PATM(%) -- -- -- --